Agent for inhibiting weight loss and body temperature loss caused by influenza virus comprising alarin as main ingredient

摘要

The present invention is a novel use of Alarin, which is derived from a splice variant of Galanin-like peptide (GALP) RNA and has an amino acid sequence similar to that of Galanin. Alarin-based acute inflammation caused by influenza virus It relates to use as an agent for suppressing hyperimmune and lowering of immunity, further improving immunity, and treating inflammation. The therapeutic agent for acute inflammation and immunosuppression caused by influenza virus of the present invention includes allarin as a main component. The weight loss and body temperature lowering inhibitor caused by the influenza virus containing allarin as a main component of the present invention configured as described above contains allarin, a kind of peptide that is present in the living body and can be simply synthesized, as a main component. Acute influenza virus caused by influenza virus that can be obtained simply and can be safely used because it does not cause specific side effects in the human body while providing therapeutic efficacy by effectively inhibiting the proliferation and survival of influenza virus at a specific concentration in a subject infected with the influenza virus It has an excellent action effect to provide an agent for inhibiting and treating inflammation and immunosuppression.